Skip to main content
Top
Published in: Trials 1/2022

Open Access 01-12-2022 | Correction

Correction to: SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion

Authors: Sarah Halford, Susan Wan, Ilaria Dragoni, Julie Silvester, Bobojon Nazarov, Daniel Anthony, Suzie Anthony, Emma Ladds, John Norrie, Kevin Dhaliwal, and the CDD SPIKE-1 Project Team

Published in: Trials | Issue 1/2022

Login to get access

Excerpt

Correction to: Trials 22, 550 (2021)
Metadata
Title
Correction to: SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion
Authors
Sarah Halford
Susan Wan
Ilaria Dragoni
Julie Silvester
Bobojon Nazarov
Daniel Anthony
Suzie Anthony
Emma Ladds
John Norrie
Kevin Dhaliwal
and the CDD SPIKE-1 Project Team
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Trials / Issue 1/2022
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-022-06266-0

Other articles of this Issue 1/2022

Trials 1/2022 Go to the issue